The law’s new $2,000 out-of-pocket spending cap for prescription drugs is expected to save most affected enrollees an average of $2,474, representing a 48% reduction in their overall spending, including premiums and cost sharing, according to the report published by AARP.
The analysis, which incorporates 2025 Part D plan premium data, estimates that 94% of enrollees expected to reach the $2,000 cap will benefit from these savings. More than 60% of these individuals will save more than $1,000, while about 12% will save more than $5,000.
Although recent changes to Part D premiums have raised concerns, the savings from lower cost sharing more than offset the premium increases for most enrollees, according to the report.
At the Becker's 11th Annual IT + Revenue Cycle Conference: The Future of AI & Digital Health, taking place September 14–17 in Chicago, healthcare executives and digital leaders from across the country will come together to explore how AI, interoperability, cybersecurity, and revenue cycle innovation are transforming care delivery, strengthening financial performance, and driving the next era of digital health. Apply for complimentary registration now.
